{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:16:34Z","timestamp":1792124194110,"version":"4.4.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jcf.2024.08.007","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:07:27Z","timestamp":1727237247000},"page":"1055-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Cystic fibrosis foundation position paper: Redefining the CF care model"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5467-5423","authenticated-orcid":false,"given":"D.M.","family":"Goetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-4587","authenticated-orcid":false,"given":"R.F.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4347-7397","authenticated-orcid":false,"given":"S.S.","family":"Filigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Bichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5636-7509","authenticated-orcid":false,"given":"R.","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Hempstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6709-4588","authenticated-orcid":false,"given":"Q.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-4112","authenticated-orcid":false,"given":"A.W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-6879","authenticated-orcid":false,"given":"P.A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.08.007_bib0001","series-title":"Cyst Fibros Found","article-title":"Clinical practice guidelines for cystic fibrosis","author":"Aitken","year":"1997"},{"key":"10.1016\/j.jcf.2024.08.007_bib0002","unstructured":"Foundation C.F. Clinical Care Guidelines. [cited 2024 June 18]. Available from: https:\/\/www.cff.org\/medical-professionals\/clinical-care-guidelines."},{"key":"10.1016\/j.jcf.2024.08.007_bib0003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcf.2023.02.009","article-title":"Cystic fibrosis prevalence in the United States and participation in the cystic fibrosis foundation patient registry in 2020","volume":"22","author":"Cromwell","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0004","series-title":"Preparation","article-title":"2023 Annual data report","year":"2024"},{"key":"10.1016\/j.jcf.2024.08.007_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1176815","article-title":"Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis","volume":"14","author":"Olivier","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1164\/rccm.202008-3177OC","article-title":"Ivacaftor in infants aged 4 to <12 months with cystic fibrosis and a gating mutation. Results of a two-part phase 3 clinical trial","volume":"203","author":"Davies","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.03.012","article-title":"Safety and efficacy of ivacaftor in infants aged 1 to <4 months with cystic fibrosis","author":"McNally","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0008","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.chest.2022.07.008","article-title":"Treatment preference among people with cystic fibrosis: the importance of reducing treatment burden","volume":"162","author":"Cameron","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.08.007_bib0009","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jcf.2019.11.007","article-title":"Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy","volume":"19","author":"Gifford","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0010","first-page":"23","article-title":"Transition to adult care in cystic fibrosis: the challenges and the structure","volume":"41","author":"Singh","year":"2022","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.08.007_bib0011","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ccm.2023.03.011","article-title":"Aiming to improve equity in pulmonary health: cystic fibrosis","volume":"44","author":"Oates","year":"2023","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0012","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201711-2357OC","article-title":"Disparities in mortality of hispanic patients with cystic fibrosis in the United States. A national and regional cohort study","volume":"198","author":"Rho","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0013","first-page":"215","volume":"18","author":"Oates","year":"2021"},{"key":"10.1016\/j.jcf.2024.08.007_bib0014","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.14-2189","article-title":"Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California","volume":"149","author":"Buu","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.08.007_bib0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0016","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2023.05.012","article-title":"Telehealth in cystic fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a 'top 10 manuscripts' to inform future best practices implementation","volume":"22","author":"Vagg","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0017","article-title":"Telemedicine in cystic fibrosis","volume":"26","author":"Desimone","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2024.08.007_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2021.09.006","article-title":"Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors","volume":"20","author":"Albon","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13071041","article-title":"Telemedicine and its application in cystic fibrosis","volume":"13","author":"Fainardi","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients","volume":"40","author":"Shah","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jcf.2024.08.007_bib0022","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Cystic Fibrosis","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical practice guidelines from the cystic fibrosis foundation for preschoolers with cystic fibrosis","volume":"137","author":"Lahiri","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.08.007_bib0024","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrosis adult care: consensus conference report","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.08.007_bib0025","unstructured":"Prevention CfDCa. Pneumococcal Vaccination: Summary of Who and When to Vaccinate. 2023 September 22, 2023 June 18]. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who-when-to-vaccinate.html#adults-19-64."},{"key":"10.1016\/j.jcf.2024.08.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2021-001529","article-title":"Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process","volume":"10","author":"Compton","year":"2021","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.jcf.2024.08.007_bib0027","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0028","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00247-022-05522-4","article-title":"Chest radiography and computed tomography imaging in cystic fibrosis: current challenges and new perspectives","volume":"53","author":"Ciet","year":"2023","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0029","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.08.007_bib0030","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcf.2019.08.017","article-title":"Cystic fibrosis bone disease treatment: current knowledge and future directions","volume":"18","author":"Putman","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0031","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Clinical practice guidelines on G, nutrition S, Ad Hoc working G. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.jcf.2024.08.007_bib0032","first-page":"273","article-title":"Screening for lipid disorders in adults: recommendations and rationale","volume":"65","year":"2002","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.jcf.2024.08.007_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0749-3797(01)00266-5","article-title":"Screening adults for lipid disorders: recommendations and rationale","volume":"20","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0034","first-page":"140","article-title":"Subcommittee on S, management of high blood pressure in C. Clinical practice guideline for screening and management of high blood pressure in children and adolescents","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.08.007_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7326\/M15-2223","article-title":"Screening for high blood pressure in adults: U.S. preventive services task force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0036","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcf.2023.08.002","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis","volume":"22","author":"Hergenroeder","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0037","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcf.2023.04.019","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis","volume":"22","author":"Schembri","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0038","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American diabetes association and a clinical practice guideline of the cystic fibrosis foundation, endorsed by the pediatric endocrine society","volume":"33","author":"Moran","year":"2010","journal-title":"Diab Care"},{"key":"10.1016\/j.jcf.2024.08.007_bib0039","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental H, group ETS. International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.08.007_bib0040","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jcf.2016.04.006","article-title":"Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis","volume":"15","author":"Cohen-Cymberknoh","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0041","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/nop2.382","article-title":"Promoting self-efficacy in patients with chronic disease beyond traditional education: a literature review","volume":"7","author":"Farley","year":"2020","journal-title":"Nurs Open"},{"key":"10.1016\/j.jcf.2024.08.007_bib0042","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1513\/AnnalsATS.202211-951OC","article-title":"Gaps in cystic fibrosis care are associated with reduced lung function in the U.S. Cystic fibrosis foundation patient registry","volume":"20","author":"Sears","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.08.007_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113812","article-title":"Predictors of transition outcomes in cystic fibrosis: analysis of national patient registry and CF RISE (Responsibility. Independence. Self-care. Education) data","volume":"265","author":"Melton","year":"2024","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0044","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/1440-1630.12899","article-title":"Occupations and balance during the transition to motherhood with a lifetime chronic illness: a scoping review examining cystic fibrosis, asthma, and Type-1 diabetes","volume":"70","author":"Haines","year":"2023","journal-title":"Aust Occup Ther J"},{"key":"10.1016\/j.jcf.2024.08.007_bib0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1513\/AnnalsATS.202305-459ED","article-title":"Falling through the cracks-the impact of care gaps on lung function loss in cystic fibrosis","volume":"20","author":"Love","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.08.007_bib0046","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Investigators, coordinators of the epidemiologic study of cystic F. Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0047","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ppul.23217","article-title":"Risk factors for lung function decline in a large cohort of young cystic fibrosis patients","volume":"50","author":"Cogen","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0048","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0049","first-page":"224","article-title":"Development of an interdisciplinary telehealth care model in a pediatric cystic fibrosis center","volume":"2","author":"Enochs","year":"2021","journal-title":"Telemed Rep"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2024.08.007_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2021.08.035","article-title":"Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network","volume":"20","author":"Ong","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0051","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2022.07.002","article-title":"Telehealth and CFTR modulators: accelerating innovative models of cystic fibrosis care","volume":"22","author":"Prickett","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2024.08.007_bib0052","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2021.09.005","article-title":"Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic","volume":"20","author":"Solomon","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0053","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MCP.0000000000000968","article-title":"Telemedicine and remote monitoring in cystic fibrosis","volume":"29","author":"Edmondson","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0054","doi-asserted-by":"crossref","first-page":"ooac005","DOI":"10.1093\/jamiaopen\/ooac005","article-title":"Cystic fibrosis telemedicine in the era of COVID-19","volume":"5","author":"Rad","year":"2022","journal-title":"JAMIA Open"},{"key":"10.1016\/j.jcf.2024.08.007_bib0055","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0056","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcf.2021.09.018","article-title":"The feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB-CF","volume":"21","author":"Edmondson","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0057","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longitudinal outcomes in cystic fibrosis","volume":"21","author":"Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0058","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/ppul.26602","article-title":"Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: results from the CLIMB-CF study","volume":"58","author":"Edmondson","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0059","unstructured":"ClinicalTrials.gov. Observational Study Comparing Home to Office Spirometry (OUTREACH). 2024 January 11 2024, [cited 2024 June 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05285410."},{"key":"10.1016\/j.jcf.2024.08.007_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12144735","article-title":"Pulmonary function tests in the evaluation of early lung disease in cystic fibrosis","volume":"12","author":"Walicka-Serzysko","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0061","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1513\/AnnalsATS.202304-317OC","article-title":"Prognostic value of CiCFSG. Cardiopulmonary exercise testing provides prognostic information in advanced cystic fibrosis lung disease","volume":"21","author":"Radtke","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.08.007_bib0062","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4187\/respcare.06185","article-title":"Peak oxygen uptake and mortality in cystic fibrosis: systematic review and meta-analysis","volume":"64","author":"Vendrusculo","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2024.08.007_bib0063","unstructured":"Prevention CfDCa. Physical Activity Basics and Your Health. March 26, 2024 [cited 2024 June 25]. Available from: https:\/\/www.cdc.gov\/physical-activity-basics\/about\/index.html."},{"key":"10.1016\/j.jcf.2024.08.007_bib0064","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/apa.16302","article-title":"Chest X-rays are less sensitive than multiple breath washout examinations when it comes to detecting early cystic fibrosis lung disease","volume":"111","author":"Svedberg","year":"2022","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.08.007_bib0066","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/thoraxjnl-2020-216085","article-title":"Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis","volume":"76","author":"Bayfield","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.08.007_bib0067","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1164\/rccm.202102-0278OC","article-title":"Magnetic resonance imaging detects progression of lung disease and impact of newborn screening in preschool children with cystic fibrosis","volume":"204","author":"Stahl","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0068","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.202107-1727ED","article-title":"Foretelling early lung disease progression in cystic fibrosis: the combined benefits of magnetic resonance imaging and newborn screening","volume":"204","author":"Goralski","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.08.007_bib0069","first-page":"S40","article-title":"Novel imaging techniques for cystic fibrosis lung disease","volume":"56","author":"Goralski","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.2020201138","article-title":"Expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: fleischner society position paper","volume":"297","author":"Hatabu","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jcf.2024.08.007_bib0071","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MPG.0000000000002694","article-title":"Cystic fibrosis-related liver disease is associated with increased disease burden and endocrine comorbidities","volume":"70","author":"Singh","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0072","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.08.007_bib0073","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Society for healthcare epidemiology of A. Infection prevention and control guideline for cystic fibrosis: 2013 update","volume":"35","author":"Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0074","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/503485","article-title":"Cystic fibrosis F. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission","volume":"24","author":"Saiman","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0075","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MCP.0000000000000616","article-title":"Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis","volume":"25","author":"Zemanick","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0076","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2018.04.002","article-title":"Eradication of early P. aeruginosa infection in children <7 years of age with cystic fibrosis: the early study","volume":"18","author":"Ratjen","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0077","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/ppul.25421","article-title":"Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis","volume":"56","author":"Lenhart-Pendergrass","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0078","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/ppul.26690","article-title":"Real-life experience with a generic formulation of lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation","volume":"58","author":"Teper","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0079","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1513\/AnnalsATS.201907-493OC","article-title":"Changes in airway microbiome and inflammation with ivacaftor treatment in patients with cystic fibrosis and the G551D mutation","volume":"17","author":"Harris","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.08.007_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcf.2023.10.019","article-title":"Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis","volume":"23","author":"Maher","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0081","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amjms.2024.02.001","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on respiratory colonization in an adult cystic fibrosis clinic","volume":"367","author":"Szabo","year":"2024","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcf.2024.08.007_bib0082","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01008-2023","article-title":"Long-term therapy with elexacaftor\/tezacaftor\/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist","volume":"62","author":"Tunney","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.08.007_bib0083","first-page":"133","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","author":"Nichols","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2024.08.007_bib0084","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00519-24","article-title":"Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis","volume":"15","author":"Armbruster","year":"2024","journal-title":"MBio"},{"key":"10.1016\/j.jcf.2024.08.007_bib0085","first-page":"51","article-title":"The clinical significance of oropharyngeal cultures in young children with cystic fibrosis","author":"Breuer","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.08.007_bib0086","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V","article-title":"Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis","volume":"28","author":"Rosenfeld","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0087","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ppul.23150","article-title":"Sputum induction improves detection of pathogens in children with cystic fibrosis","volume":"50","author":"Hoppe","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0088","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","article-title":"US Cystic fibrosis foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.08.007_bib0089","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis","volume":"162","author":"Yen","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0091","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0092","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jcf.2023.05.010","article-title":"Nutritional considerations for a new era: a CF foundation position paper","volume":"22","author":"Leonard","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0093","series-title":"Foundation CF","article-title":"2022 Annual data report","year":"2023"},{"key":"10.1016\/j.jcf.2024.08.007_bib0094","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcf.2022.08.008","article-title":"Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: a scoping review","volume":"22","author":"Ramsey","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0095","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jcf.2023.09.005","article-title":"Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis","volume":"22","author":"Stephenson","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107455","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: an expert-based Delphi consensus","volume":"220","author":"Gramegna","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0097","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of Nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2024.08.007_bib0098","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ncp.10247","article-title":"Tools and methods used for the assessment of body composition in patients with cystic fibrosis: a systematic review","volume":"34","author":"Calella","year":"2019","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcf.2024.08.007_bib0099","article-title":"Body composition in individuals with cystic fibrosis","volume":"26","author":"Soltman","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.jcf.2024.08.007_bib0101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40348-024-00178-6","article-title":"Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight","volume":"11","author":"Fabricius","year":"2024","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.jcf.2024.08.007_bib0102","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ppul.26823","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lipid and fat-soluble vitamin levels and association with body mass index","volume":"59","author":"Patel","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0103","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jcjo.2021.04.018","article-title":"Papilledema and hypervitaminosis A after elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis","volume":"57","author":"Miller","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0104","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jcf.2022.01.010","article-title":"Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis","volume":"21","author":"Wisniewski","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ppul.25781","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on vitamin D absorption in cystic fibrosis patients","volume":"57","author":"Wright","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0106","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ppul.26805","article-title":"Analysis of iron status after initiation of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis","volume":"59","author":"James","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.03.002","article-title":"Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis","author":"Jia","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0108","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jcf.2023.10.002","article-title":"Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis","volume":"22","author":"Despotes","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0109","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0110","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/HYP.0000000000000228","volume":"80","author":"Falkner","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jcf.2024.08.007_bib0111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0112","unstructured":"Daniels S.R. Guidelines for screening, prevention, diagnosis and treatment of dyslipidemia in children and adolescents. In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K, Hofland J., Kalra S., Kaltsas G., Kapoor N., Koch C., Kopp P., Korbonits M., Kovacs C.S., Kuohung W., Laferrere B., Levy M., McGee E.A., McLachlan R., New M., Purnell J., Sahay R., Shah A.S., Singer F., Sperling M.A., Stratakis C.A., Trence D.L., Wilson D.P., editors. Endotext. South Dartmouth (MA); 2000."},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.08.007_bib0113","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","article-title":"Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis","volume":"18","author":"Granados","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0114","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/clinem\/dgad443","article-title":"Preservation of beta-cell function in pancreatic insufficient cystic fibrosis with highly effective CFTR modulator therapy","volume":"109","author":"Flatt","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.08.007_bib0115","first-page":"23","article-title":"Cystic fibrosis related diabetes (CFRD) in the era of modulators: a scoping review","volume":"46","author":"Prentice","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.08.007_bib0116","article-title":"The role of modulators in cystic fibrosis related diabetes","volume":"27","author":"Merjaneh","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0117","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2021.09.001","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor (ETI) on glycemia in adults with cystic fibrosis","volume":"21","author":"Scully","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clnesp.2023.08.028","article-title":"Effect of 18 months elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosis","volume":"58","author":"Taelman","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.jcf.2024.08.007_bib0119","article-title":"Treatment of cystic fibrosis related bone disease","volume":"27","author":"Ullal","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ppul.26243","article-title":"Effect of Trikafta on bone density, body composition and exercise capacity in CF: a pilot study","volume":"58","author":"Gur","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0121","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1210\/clinem\/dgaa890","article-title":"The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis","volume":"106","author":"Putman","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2024.08.007_bib0122","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening task F. Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2024.08.007_bib0123","unstructured":"ClinicalTrials.gov. Colorectal Cancer Screening in Cystic Fibrosis (NICE-CF). 2024 May 28, 2024 [cited 2024 June 18]."},{"key":"10.1016\/j.jcf.2024.08.007_bib0124","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chest.2021.09.003","article-title":"Cancer in cystic fibrosis: a narrative review of prevalence, risk factors, screening, and treatment challenges: adult cystic fibrosis series","volume":"161","author":"Maisonneuve","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.08.007_bib0125","first-page":"90","article-title":"Gastrointestinal malignancy in cystic fibrosis","volume":"35","author":"Hough","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2024.08.007_bib0126","first-page":"15","article-title":"Cystic fibrosis and cancer: unraveling the complex role of CFTR gene in cancer susceptibility","author":"Parisi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcf.2024.08.007_bib0127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-019-1052-7","article-title":"Case report of synchronous post-lung transplant colon cancers in the era of colorectal cancer screening recommendations in cystic fibrosis: screening \"too early\" before it's too late","volume":"19","author":"Abraham","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0128","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccm.2022.06.014","article-title":"Management of mental health in cystic fibrosis","volume":"43","author":"Bathgate","year":"2022","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106955","article-title":"Mental health screening in cystic fibrosis as an intervention: patient and caregiver feedback on improving these processes","volume":"202","author":"Landau","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jpm.2020.0311","article-title":"Models of palliative care delivery for individuals with cystic fibrosis: cystic fibrosis foundation evidence-informed consensus guidelines","volume":"24","author":"Kavalieratos","year":"2021","journal-title":"J Palliat Med"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2024.08.007_bib0131","first-page":"S107","article-title":"Promoting emotional wellness in children with CF, part II: mental health assessment and intervention","volume":"56","author":"Georgiopoulos","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0132","doi-asserted-by":"crossref","first-page":"e47047","DOI":"10.2196\/47047","article-title":"Telehealth and in-person behavioral health services in rural communities before and during the COVID-19 pandemic: multisite prospective cohort study","volume":"10","author":"Ward","year":"2023","journal-title":"JMIR Ment Health"},{"key":"10.1016\/j.jcf.2024.08.007_bib0133","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamapsychiatry.2020.1011","article-title":"Coached mobile app platform for the treatment of depression and anxiety among primary care patients: a randomized clinical trial","volume":"77","author":"Graham","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jcf.2024.08.007_bib0134","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3122\/jabfm.2022.03.210377","article-title":"Patient and clinician perspectives on two telemedicine approaches for treating patients with mental health disorders in underserved areas","volume":"35","author":"Hall","year":"2022","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chc.2010.09.003","article-title":"The use of telemedicine in pediatric psychology: research review and current applications","volume":"20","author":"Van Allen","year":"2011","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jcf.2024.08.007_bib0136","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/nur.22089","article-title":"Using telehealth to assess depression and suicide ideation and provide mental health interventions to groups of chronically ill adolescents and young adults","volume":"44","author":"Wright","year":"2021","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jcf.2024.08.007_bib0137","unstructured":"Hinton E. A look at recent Medicaid guidance to address social determinants of health and health-related social needs. 2023 [cited 2024 June 18, 2024]. Available from: https:\/\/www.kff.org\/policy-watch\/a-look-at-recent-medicaid-guidance-to-address-social-determinants-of-health-and-health-related-social-needs\/."},{"key":"10.1016\/j.jcf.2024.08.007_bib0138","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/ppul.26131","article-title":"Social determinants of health screening and intervention: a cystic fibrosis quality improvement process","volume":"57","author":"Jennings","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0139","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/17476348.2022.2090928","article-title":"Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies","volume":"16","author":"Oates","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2024.08.007_bib0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcf.2021.06.006","article-title":"Association between insurance variability and early lung function in children with cystic fibrosis","volume":"21","author":"Dickinson","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0141","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ppul.24414","article-title":"Assessing psychosocial risk in pediatric cystic fibrosis","volume":"54","author":"Filigno","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0142","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/ppul.25850","article-title":"Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households","volume":"57","author":"Lim","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0143","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcf.2023.01.002","article-title":"Cost burden among the CF population in the United States: a focus on debt, food insecurity, housing and health services","volume":"22","author":"Seyoum","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.08.007_bib0144","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ppul.26716","article-title":"Education-related needs for children with cystic fibrosis: perspectives of US pediatric care teams","volume":"59","author":"Hjelm","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.08.007_bib0145","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amepre.2019.07.010","article-title":"Part I: a quantitative study of social risk screening acceptability in patients and caregivers","volume":"57","author":"De Marchis","year":"2019","journal-title":"Am J Prev Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324008385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T14:27:24Z","timestamp":1733236044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324008385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1569199324008385"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis foundation position paper: Redefining the CF care model","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}